Effect of plasma from patients containing bupropion and its metabolites on the uptake of norepinephrine

Neuropharmacology

Volumn 25, Issue 2, 1986, Pages 199-202

  Perumal, A S ^a   Smith, T M ^b   Suckow, R F ^a   Cooper, T B ^a,b  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

Author keywords

bupropion; correlation; inhibition; metabolites; NE uptake; plasma

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; DESIPRAMINE; NORADRENALIN; RADIOISOTOPE;

ANIMAL CELL; BRAIN CORTEX; CATECHOLAMINE UPTAKE; CENTRAL NERVOUS SYSTEM; DRUG EFFICACY; NONHUMAN; NORADRENALIN H 3; PRIORITY JOURNAL; RAT;

ANIMAL; BUPROPION; CEREBRAL CORTEX; DESIPRAMINE; FEMALE; HUMAN; NOREPINEPHRINE; PROPIOPHENONES; RATS; RATS, INBRED STRAINS; SUPPORT, NON-U.S. GOV'T; TIME FACTORS;

EID: 0022635042     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/0028-3908(86)90041-9     Document Type: Article

References (8)

1. Determination of bupropion and its major basic metabolites in plasma by liquid chromatography with dual wavelength UV detection
2. Typical and atypical antidepressants
3. 2-adrenergic, imipramine and dopaminergic receptors in brain
4. Daily bupropion injections for three weeks attenuate the NE-stimulation of adenylate cyclase and the number of β-adrenergic recognition sites in rat frontal cortex
5. Clinical efficacy of the antidepressant bupropion (Wellbutrin)
6. Effect of tricyclic antidepressants on the uptake of noradrenaline and 5-hydroxytryptamine by rat brain slices incubated in buffer or human plasma
7. Bupropion
8. Temporal sequence of changes in central noradrenergic system of rat after prolonged antidepressant treatment. Receptor desensitization and neurotransmitter interactions